Your Subcutaneous Fat Is a Solar Panel

The fitness industry has spent fifty years asking the wrong question. “How do I lose this fat?” assumes that all body fat is a liability — a cosmetic failure, a metabolic burden, a problem to be solved with caloric restriction and cardio. But what if some of that fat is doing something? What if the layer of subcutaneous tissue between your skin and your muscle isn’t storage at all — but infrastructure?

Dr. Jack Kruse, a neurosurgeon and researcher in quantum biology, has been making this argument for over a decade. His claim is provocative: subcutaneous fat is a light-harvesting organ. Not metaphorically. Literally.

Your fat sees light.

In 2017, researchers at the University of Alberta discovered that human subcutaneous white adipocytes express melanopsin — the same photoreceptor protein found in the retina — coupled to TRPC ion channels. This means your fat cells can detect and respond to light. Specifically, blue light at wavelengths of 450–480nm, at intensities that naturally penetrate skin on a sunny day, activates a signalling cascade in subcutaneous fat that shrinks lipid droplets, increases basal lipolysis, and alters the secretion of leptin and adiponectin ¹. Your fat tissue isn’t sitting there passively. On a sunny day, it’s actively metabolising — burning lipids, modulating hunger hormones, and communicating with your endocrine system. In the dark, it does none of this.

If your fat cells contain photoreceptors, then the amount of subcutaneous tissue you carry determines the size of your receptor field. This matters.

The energy compensation principle.

Bergmann’s Rule is one of the oldest observations in biology: within a species, individuals at higher latitudes tend to be larger than those closer to the equator ². The traditional explanation is thermoregulation — bigger bodies conserve heat. But Kruse extends this principle to light energy, not just thermal energy. When a biological system loses energy to its environment — less sunlight, more artificial light, more time indoors — physics demands it get larger to maintain function. The body isn’t failing when it accumulates subcutaneous fat under conditions of light deprivation. It’s adapting. It’s expanding its energy-capture surface because the light environment is impoverished.

This reframes the modern obesity epidemic not as a caloric surplus problem but as a light deficiency problem wearing a fat costume.

Three mechanisms — this is not a metaphor.

The reason a larger subcutaneous fat layer matters biologically comes down to three distinct, experimentally verified mechanisms of action.

The first is direct ATP production via infrared light. Near-infrared wavelengths between 650 and 900nm penetrate skin and subcutaneous tissue to a depth of up to 30mm. These photons are absorbed by cytochrome c oxidase — the terminal enzyme in the mitochondrial electron transport chain. When NIR light hits this enzyme, it dissociates nitric oxide from the binding site, allowing oxygen to bind more efficiently. This directly increases oxidative phosphorylation and ATP synthesis ³. This is not red light therapy marketing. This is photobiomodulation — the conversion of photon energy into cellular fuel. More subcutaneous tissue means more surface area and depth for infrared photon capture, which means more raw material for mitochondrial energy production.

The second is light-driven metabolic regulation through melanopsin. The 2017 Ondrusova discovery showed that the melanopsin/TRPC channel axis in subcutaneous adipocytes triggers intracellular calcium signalling when activated by blue light. This cascade activates calcium-sensitive PKC isoforms and modulates the calcineurin/NFAT signalling axis — a pathway known to regulate genes involved in adipocyte metabolism and lipolysis ¹. In plain language: light hitting your fat tissue directly controls how that fat is stored, mobilised, and how it talks to the rest of your body. A larger subcutaneous layer means a larger receptor field for this signalling pathway.

The third is local vitamin D production. Subcutaneous adipose tissue doesn’t just store vitamin D — it expresses the enzyme CYP27B1, which locally converts circulating D3 into its active form, calcitriol. Concentrations of active 1,25(OH)²D³ measured in abdominal subcutaneous fat have been found to be over ten-fold higher than in serum ⁴. Your fat is running its own local vitamin D signalling system — paracrine and autocrine — independent of what’s circulating in your blood. As we established in the previous article, this locally produced calcitriol is the form that drives apoptosis in abnormal cells at the tissue level. More subcutaneous fat means a larger local D3 conversion factory.

Three mechanisms. Three ways your subcutaneous fat layer captures light and converts it to biological function. None of them work in the dark.

What happens when you age.

Mitochondrial ATP production declines continuously from early adulthood, but the decline accelerates visibly around age 50–55, when mitochondrial network fragmentation becomes detectable in skeletal muscle ⁵. Cytochrome c oxidase activity drops. The electron transport chain becomes less efficient. You produce less energy per unit of food consumed.

Simultaneously, your skin’s capacity to synthesize vitamin D3 from UVB exposure drops by roughly 13% per decade. By age 60–70, you’re producing approximately half the D3 from the same sun exposure as a 20-year-old ⁶. The internal energy and signalling systems are winding down on two fronts at once.

The body’s response — expanding the subcutaneous fat layer — is not a failure of discipline. It is a compensatory adaptation: building a bigger solar panel to offset declining mitochondrial output, expanding the photoreceptor field, and enlarging the local D3 conversion factory. The critical distinction is that this only applies to subcutaneous fat, which is light-responsive. Visceral fat — the deep abdominal fat surrounding organs — does not express melanopsin, does not participate in photobiomodulation at meaningful depth, and remains metabolically pathological at any age.

The obesity paradox — explained.

Mainstream medicine has noticed something it cannot explain. A systematic review of over 1.1 million people aged 65 and older found that in 75% of studies examining patients with a medical condition, being overweight or mildly obese was associated with better survival outcomes ⁷. A large U.S. cohort study found that being overweight was actively protective against cardiovascular mortality in adults over 65 — and the effect was strongest in those over 75. The medical literature calls this the “obesity paradox” because it contradicts everything the field believes about body weight and health.

It’s only a paradox if you think fat is inert.

If subcutaneous fat is a functioning photobiological organ — capturing infrared for ATP production, responding to blue light for metabolic regulation, and running a local vitamin D conversion system — then the finding makes perfect sense. Older adults with a modest subcutaneous fat layer have more metabolic infrastructure than those without it. They have a larger solar panel at precisely the age when they need one most.

To be absolutely clear about scale.

We are not talking about obesity as it is commonly understood. We are not talking about a BMI of 35 — the data shows no protective effect at that level. We are talking about 15 to 20 pounds of subcutaneous fat above a lean baseline. If you’re 5’9” and 155 pounds, we’re talking about being 5’9” and 170 pounds — and that additional tissue being metabolically useful, if not downright essential, past a certain age. For most people, the convergence point where mitochondrial decline, reduced D3 synthesis, and diminished photoreceptor efficiency all intersect meaningfully is somewhere in the late 50s to mid 60s.

And there is one enormous caveat.

This entire framework depends on light. An older person carrying 15–20 extra pounds of subcutaneous fat who lives outdoors in sunlight is in a fundamentally different metabolic position than someone carrying the same weight under fluorescent lights. The fat is only protective if it’s being charged. Without sunlight, subcutaneous fat is just mass. The three mechanisms — infrared ATP production, melanopsin-driven lipolysis, local D3 conversion — all require photon input. Without it, you don’t have a solar panel. You have dead weight.

Consider what this means for someone carrying that extra 15–20 pounds in a city like Toronto. From November through March, UVB intensity is too low to produce any meaningful vitamin D in the skin. Office workers commute in the dark, sit under fluorescent lights for eight hours, and commute home in the dark. The melanopsin receptors in their subcutaneous fat receive virtually zero activation. The infrared-to-ATP pathway sits idle. The local D3 conversion factory has no substrate to convert. Meanwhile, the metabolic consequences of carrying uncharged fat accumulate — insulin sensitivity degrades, systemic inflammation rises, leptin signalling becomes dysregulated, and the cardiovascular burden of the extra mass continues without any of the photobiological offset. The same 15 pounds that would be protective on a 62-year-old in southern Spain becomes a genuine liability on a 62-year-old in a Toronto high-rise. The fat isn’t the variable. The light is.

The question was never “how do I get rid of this fat?” The question is “am I giving this fat the light it was designed to receive?” If you are, your body will find its own set point. If you’re not, no diet will fix what darkness broke.